Kinder Morgan (KMI) reported earnings after the bell on Wednesday, highlighting growth opportunities in natural gas. Kinder Morgan reaffirmed that expected natural gas demand growth will have a substantial positive impact on the company.
Morgan Stanley MS stock received price target increases from analysts after beating Street estimates and showing strength across multiple company segments in third-quarter financial results.
Elevance Health, Inc. (NYSE:ELV ) Q3 2024 Results Conference Call October 17, 2024 8:30 AM ET Company Participants Steve Tanal - Vice President of Investor Relations Gail Boudreaux - President and CEO Mark Kaye - CFO Pete Haytaian - President, Carelon Morgan Kendrick - President, Commercial Health Benefits Felicia Norwood - President, Government Health Benefits Conference Call Participants A.J. Rice - UBS Stephen Baxter - Wells Fargo Ben Hendrix - RBC Capital Markets Ann Hynes - Mizuho Erin Wright - Morgan Stanley Justin Lake - Wolfe Research Lisa Gill - JPMorgan Lance Wilkes - Bernstein Josh Raskin - Nephron Research Michael Hall - Baird Ryan Langston - Cowen Scott Fidel - Stephens Whit Mayo - Leerink Partners Sarah James - Cantor Fitzgerald Dave Windley - Jefferies Joanna Gajuk - Bank of America George Hill - Deutsche Bank Operator Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health Third Quarter Earnings Conference Call.
Natural gas has become the dominant power source in the US, with Kinder Morgan benefiting from stable production and higher export demand. KMI's stock price has risen 40% this year, outperforming its peers, but its forward dividend yield has compressed to 4.6%, well below its 6-7% yielding peers. KMI is more of a dividend aristocrat than a growth company. It has limited growth potential and more focus on dividend stability and cash flow.
KMI Q3 earnings get affected by decreased financial contributions from two segments. However, this is partially offset by lower total costs and expenses.
Morgan Stanley's earnings surpassed expectations, driving a 6.5% stock surge. Strong performance in all segments led to the company gaining the highest one-day return compared to the other banks after reporting Q3 earnings. Despite a positive investment banking outlook, the stock remains expensive, with a PE of 18.1x and a PEG of 2.48x. Given the outlook, rapid growth, and valuation, I reiterate my "buy rating" on Morgan Stanley's stock.
U.S. pipeline operator Kinder Morgan fell short of Wall Street estimates for third-quarter profit on Wednesday, weighed down by weaker commodity prices and lower crude volumes.
Ted Pick expects a sleepy IPO market to start waking up.
Thomas Martin, Globalt Investments senior portfolio manager, joins ‘Power Lunch' to discuss stock plays for three stocks.
Morgan Stanley Chief Executive Officer Ted Pick speaks to Bloomberg's Sonali Basak in New York after the bank reported better-than-expected revenue in the third quarter. Shares rose sharply on the news.
Both Imports and Exports were deeper into the negative than expected. Meanwhile, MS, ABT and USB all beat of Q3 earnings.
Shares of Morgan Stanley (NYSE:MS) are up 7.5% to trade at $120.66 this morning, after the company posted a third-quarter beat , with an earnings per share of $1.88 on $3.19 billion in revenue.